CEMI - Chembio Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 1.68
52-Week Change 3-31.25%
S&P500 52-Week Change 318.08%
52 Week High 37.9000
52 Week Low 33.9500
50-Day Moving Average 35.2078
200-Day Moving Average 35.9812

Share Statistics

Avg Vol (3 month) 356.59k
Avg Vol (10 day) 398.12k
Shares Outstanding 517.57M
Float 13.76M
% Held by Insiders 111.32%
% Held by Institutions 144.94%
Shares Short (Oct 31, 2019) 4216.55k
Short Ratio (Oct 31, 2019) 45.36
Short % of Float (Oct 31, 2019) 41.33%
Short % of Shares Outstanding (Oct 31, 2019) 41.23%
Shares Short (prior month Sep 30, 2019) 4163.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3May 30, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin -37.87%
Operating Margin (ttm)-36.58%

Management Effectiveness

Return on Assets (ttm)-18.43%
Return on Equity (ttm)-57.00%

Income Statement

Revenue (ttm)34.21M
Revenue Per Share (ttm)2.05
Quarterly Revenue Growth (yoy)-1.10%
Gross Profit (ttm)3.46M
Net Income Avi to Common (ttm)-12.96M
Diluted EPS (ttm)-0.7800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.87M
Total Cash Per Share (mrq)1.25
Total Debt (mrq)24.93M
Total Debt/Equity (mrq)96.65
Current Ratio (mrq)5.86
Book Value Per Share (mrq)1.47

Cash Flow Statement

Operating Cash Flow (ttm)-10.65M
Levered Free Cash Flow (ttm)-9.36M